Success
breeds its own orthodoxy. When an
innovation defies the odds and not only survives but succeeds, it is perfectly
natural to want to continue that success by perpetuating what is believed to
have contributed to the success in the first place. What those contributing factors were,
however, may be more subject to multiple interpretations and perceptions than
some might first admit. This is where
the next “orthodoxy” starts to sneak in.
We
have been working with a company recently whose success has attracted many
competitors on the outside. Success has
also required internal attention and effort to order, control and focus the
innovation-born success on the inside, the need for which is not unrelated to
the intensifying competition on the outside.
The dilemma facing this post-entrepreneurial stage company now is how to
protect, defend and perpetuate its success while at the same time continuing to
fulfill its vocation of providing innovative value to current and new
consumers. Sound familiar?
As
whole companies or even product divisions seek to extend their success, they
naturally develop “immune systems” designed to maintain the health of the
organization. Just as our physical
health depends upon a robust immune system – a complex network of cells and
molecules that normally work to defend the body and eliminate infections caused
by bacteria, viruses and other invading microbes – business “fitness” depends
to some degree on a corporate immune system.
These corporate “immune systems” can be comprised of a complex set of
management attitudes (e.g., focus), decisions (e.g., resource allocations) and
controls that serve to protect, defend and perpetuate the value proposition for
customers and the resulting profits for the corporation.
However,
when organizational fitness becomes more important than business fitness,
orthodoxy can set in, creating conditions for the corporate “immune system” to
attack the corporation’s own innovation efforts, mistaking these efforts as
threats or “antigens.” Just as immune
cells can mistake our bodies’ own cells as invaders and attack them, internally
developed or externally sponsored innovations can elicit “friendly fire,” in some
very subtle ways. In other words, well-intentioned
and otherwise necessary corporate “immune systems” can sometimes
unintentionally turn on the host and become what the medical profession refers
to as “autoimmunity.”
“Corporate
autoimmunity” frequently happens when the organization’s own need for order
becomes more important than its purpose of providing (new) value to customers or
consumers. A classic example of an
“autoimmune” response to an early stage innovation effort is when a large
corporation seeking to innovate disqualifies an effort based upon size of
market. “We are only looking for billion
dollar businesses,” failing to remember that the billion dollar business they
are currently defending once started with relatively small and more humble
beginnings.
Clayton
Christensen points to four subtle, but deadly “autoimmune” responses to
innovation in his new book The
Innovator’s Solution. Christensen
says there are at least four reasons in established companies that cause managers to target innovations
that are not aligned with the way that customers live their lives (page
86). “The first two reasons – the fear
of focus and the demand for crisp quantification – reside in companies’
resources allocation processes. The
third reason is that the structure of many retail channels is attribute [rather
than customer] focused. The fourth
reason is that advertising economics influence companies to target products at
customers rather than [their] circumstances.”
In
other words, both internal (e.g., resource allocation) and external (e.g., comparisons
to competition or conformity to the way retailers organize their aisles)
orthodoxies that grow up around attempts to perpetuate an innovation’s success,
frequently cause us to take our eye off the “ball” of opportunity – what
Christensen describes as a “sharp focus on jobs that customers (or consumers)
are trying to get done.”
Might
this be the place to discover “heresy” with which to break out of the orthodoxy
of success and start the next innovation in new value to customers?
This article was originally published in Innovating Perspectives in November 2003.
For this and other back issues of our newsletter,
please visit our website at
innovationsthatwork.com or call (415) 387-1270.